Terms: = Breast cancer AND P2RY8, RP11-261P4_4, 286530, ENSG00000182162, MGC50878, P2Y8, Q86VZ1 AND Prognosis
6324 results:
1. Additional prognostic value of polymorphisms within the 3'-untranslated region of programmed cell death pathway genes in early-stage breast cancer.
Chen H; Chen M; Zeng B; Tang L; Nie Q; Jin X; Guo W; Chen L; Lin Y; Wang C; Fu F
Front Immunol; 2024; 15():1284579. PubMed ID: 38690279
[TBL] [Abstract] [Full Text] [Related]
2. Loss of tumor-derived SMAD4 enhances primary tumor growth but not metastasis following BMP4 signalling.
Chi LH; Redfern AD; Roslan S; Street IP; Burrows AD; Anderson RL
Cell Commun Signal; 2024 Apr; 22(1):248. PubMed ID: 38689334
[TBL] [Abstract] [Full Text] [Related]
3. Germline biallelic BRCA2 pathogenic variants and medulloblastoma: an international cohort study.
Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
[TBL] [Abstract] [Full Text] [Related]
4. Deubiquitination of CDC6 by OTUD6A promotes tumour progression and chemoresistance.
Cui J; Liu X; Shang Q; Sun S; Chen S; Dong J; Zhu Y; Liu L; Xia Y; Wang Y; Xiang L; Fan B; Zhan J; Zhou Y; Chen P; Zhao R; Liu X; Xing N; Wu D; Shi B; Zou Y
Mol Cancer; 2024 Apr; 23(1):86. PubMed ID: 38685067
[TBL] [Abstract] [Full Text] [Related]
5. Crosstalk of disulfidptosis-related subtypes identifying a prognostic signature to improve prognosis and immunotherapy responses of clear cell renal cell carcinoma patients.
Ren L; Liu J; Lin Q; He T; Huang G; Wang W; Zhan X; He Y; Huang B; Mao X
BMC Genomics; 2024 Apr; 25(1):413. PubMed ID: 38671348
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of large language models in breast cancer clinical scenarios: a comparative analysis based on ChatGPT-3.5, ChatGPT-4.0, and Claude2.
Deng L; Wang T; Yangzhang ; Zhai Z; Tao W; Li J; Zhao Y; Luo S; Xu J
Int J Surg; 2024 Apr; 110(4):1941-1950. PubMed ID: 38668655
[TBL] [Abstract] [Full Text] [Related]
7. Impact of Pregnancy on breast cancer Features and prognosis.
Bounous VE; Minella C; Fuso L; Actis S; Petroni G; Sgrò LG; Borghese M; Tomasi Cont N; Ponzone R; Ferrero A
Curr Oncol; 2024 Apr; 31(4):2305-2315. PubMed ID: 38668074
[TBL] [Abstract] [Full Text] [Related]
8. Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling.
Wang S; Li J; Hong S; Wang N; Xu S; Yang B; Zheng Y; Zhang J; Pan B; Hu Y; Wang Z
J Exp Clin Cancer Res; 2024 Apr; 43(1):121. PubMed ID: 38654356
[TBL] [Abstract] [Full Text] [Related]
9. [Role of neoadjuvant rectal score in prognosis and adjuvant chemotherapy decision-making in locally advanced rectal cancer following neoadjuvant short-course radiotherapy and consolidation chemotherapy].
Zeng Q; Tang Y; Zhou HT; Li N; Liu WY; Chen SL; Li S; Lu NN; Fang H; Wang SL; Liu YP; Song YW; Li YX; Jin J
Zhonghua Zhong Liu Za Zhi; 2024 Apr; 46(4):335-343. PubMed ID: 38644269
[No Abstract] [Full Text] [Related]
10. Clinical relevance of glycosylation in triple negative breast cancer: a review.
Chakraborty M; Kaur J; Gunjan ; Kathpalia M; Kaur N
Glycoconj J; 2024 Apr; 41(2):79-91. PubMed ID: 38634956
[TBL] [Abstract] [Full Text] [Related]
11. PFDN4 as a Prognostic Marker Was Associated with Chemotherapy Resistance through CREBP1/AURKA Pathway in Triple-Negative breast cancer.
Wang SH; Yeh CH; Wu CW; Hsu CY; Tsai EM; Hung CM; Wang YW; Hsieh TH
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612711
[TBL] [Abstract] [Full Text] [Related]
12. Selective omission of sentinel lymph node biopsy in mastectomy for ductal carcinoma in situ: identifying eligible candidates.
Bae SJ; Kook Y; Jang JS; Baek SH; Moon S; Kim JH; Lee SE; Kim MJ; Ahn SG; Jeong J
Breast Cancer Res; 2024 Apr; 26(1):65. PubMed ID: 38609935
[TBL] [Abstract] [Full Text] [Related]
13. Impact of chrono-radiotherapy on the prognosis and treatment-related toxicity in patients with locally advanced nasopharyngeal carcinoma: A multicenter propensity-matched study.
Lin J; Lin X; Zheng R; Lin K; Khan M; Huang X; Tian Y; Wang B; Xu B; Yuan Y; Huang Z
Chronobiol Int; 2024 Apr; 41(4):587-597. PubMed ID: 38606920
[TBL] [Abstract] [Full Text] [Related]
14. Significance of Estrogen/Progesterone Receptor Expression in Metaplastic breast Carcinoma.
Hashmi AA; Mallick BA; Rashid K; Malik UA; Zia S; Zia F; Irfan M
Dis Markers; 2024; 2024():2540356. PubMed ID: 38601434
[TBL] [Abstract] [Full Text] [Related]
15. Insights into breast cancer Knowledge Among Female Adolescents in Delta State, Nigeria: A School-Based Study.
Akpo MO; Akpo EE; Akpo DO
West Afr J Med; 2024 Feb; 41(2):197-201. PubMed ID: 38583066
[TBL] [Abstract] [Full Text] [Related]
16. Activation of the YY1-UGT2B7 Axis Promotes Mammary Estrogen Homeostasis Dysregulation and Exacerbates breast Tumor Metastasis.
Xu J; Zhou Y; He S; Wang Y; Ma J; Li C; Liu Z; Zhou X
Drug Metab Dispos; 2024 Apr; 52(5):408-421. PubMed ID: 38575184
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic and clinicopathological value of systemic inflammation response index (SIRI) in patients with breast cancer: a meta-analysis.
Zhang S; Cheng T
Ann Med; 2024 Dec; 56(1):2337729. PubMed ID: 38569199
[TBL] [Abstract] [Full Text] [Related]
18. The prognosis of patients treated with everolimus for advanced ER-positive, HER2-negative breast cancer is driven by molecular features.
Salaün H; Djerroudi L; Haik L; Schnitzler A; Bataillon G; Deniziaut G; Bièche I; Vincent-Salomon A; Debled M; Cottu P
J Pathol Clin Res; 2024 May; 10(3):e12372. PubMed ID: 38563252
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic stratification ability of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.
Roussot N; Constantin G; Desmoulins I; Bergeron A; Arnould L; Beltjens F; Mayeur D; Kaderbhai C; Hennequin A; Jankowski C; Padeano MM; Costaz H; Jacinto S; Michel E; Amet A; Coutant C; Costa B; Jouannaud C; Deblock M; Levy C; Ferrero JM; Kerbrat P; Brain E; Mouret-Reynier MA; Coudert B; Bertaut A; Ladoire S
Eur J Cancer; 2024 May; 202():114037. PubMed ID: 38554542
[TBL] [Abstract] [Full Text] [Related]
20. CD146 as a prognostic marker in breast cancer: A meta-analysis.
Sharma A; Somasundaram I; Chabaud MB
J Cancer Res Ther; 2024 Jan; 20(1):193-198. PubMed ID: 38554320
[TBL] [Abstract] [Full Text] [Related]
[Next]
